Applying Newer Diagnostic and Therapeutic Tools to the Management of the Individual with Nontuberculous Mycobacterial Lung Disease

A MECC-Organized Symposium at the ATS 2024 International Conference. This evening educational program sponsored by Med Learning Group and supported by a grant from Insmed open to all ATS 2024 International Conference attendees.

Monday, May 20, 2024

6:30 PM – 6:45 PM PT Registration & Dinner
6:45 PM – 7:45 PM PT CE Symposium

Manchester Grand Hyatt San Diego
1 Market Place
San Diego, CA 92101
Meeting Room: Grand Hall A

PROGRAM FEATURES

    • Interactive case-based presentation
    • Downloadable whiteboard animations
    • Online personalized quality-improvement poster-generation portal

FACULTY

Juzar Ali, MD
Klein LSU Alumni Professor of Medicine
Section of Pulmonary/Critical Care Medicine & Allergy/Immunology
Louisiana State University School of Medicine Health Sciences Center
New Orleans, LA
David E. Griffith, MD
Professor of Medicine
Division of Mycobacterial & Respiratory Infections
National Jewish Health
Denver, CO

PROGRAM DESCRIPTION

This satellite symposium is designed to increase the health care professional’s ability to: discuss at-risk populations and the clinical presentations of nontuberculous mycobacterial lung disease, evaluate recent and emerging data on the management of individuals with NTM-LD in concert with the development of individualized treatment goals, and describe multidisciplinary strategies to advance communication that optimizes medication adherence and minimizes adverse event morbidity.

TARGET AUDIENCE

This educational activity is designed to meet the needs of clinicians and those who have a role in the diagnosis and treatment of patients with NTM‐LD, including healthcare professionals in infectious diseases, including pulmonologists, intensivists, infectious diseases physicians, pharmacists, nurse practitioners, physician assistants, and others.

LEARNING OBJECTIVES

After completing the activity, learners should be better able to:

  • Discuss at-risk populations and the clinical presentations of nontuberculous mycobacterial lung disease
  • Evaluate recent and emerging data on the management of individuals with NTM-LD in concert with the development of individualized treatment goals
  • Describe multidisciplinary strategies to advance communication that optimizes medication adherence and minimizes adverse event morbidity

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT 

Event Staff will be glad to assist you with any special needs (ie, physical, dietary, etc.).  Please contact Med Learning Group prior to the live event at [email protected]

 

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation
BestofAmerica

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.